Biotechnology VALUE FUND II L.P., Insider at Capstone Therapeutics Corp. (CAPS), bought 312,900 shares at $0.26 ($81K) on 2011-09-06, disclosed to the SEC on 2011-09-08.
Open-market purchase of $81k CAPS by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 43,200 | $11K | 13.8% |
| 2 | $0.26 | 70,100 | $18K | 22.4% |
| 3 | $0.26 | 199,600 | $52K | 63.8% |
| Total | $0.26 avg | 312,900 | $81K | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |